Your session is about to expire
← Back to Search
Therapy arm for Snoring
Study Summary
This trial will help to improve our understanding of how the eXciteOSA device affects snoring and sleep apnoea and will provide valuable information on whether this new device is an effective treatment for these conditions.
- Snoring
- Obstructive Sleep Apnea
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had oral surgery in the past to treat snoring.You have significant abnormalities in the structure of your face, such as a small jaw or a rare facial condition.You have ongoing issues with your nose, such as a deviated septum, nasal polyps, or chronic sinus problems that cause symptoms.Your tonsils are very large (Grade 3 or higher).You have a pacemaker or any implanted medical device that uses electricity.You have been complaining about snoring for more than six months.You have a body mass index (BMI) of more than 35, which means you are severely overweight.You are female or male, aged 18 years or above.You have a tongue or lip piercing.
- Group 1: Therapy arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new enrollees accepted into this experiment?
"Contrary to popular belief, this clinical trial is not presently recruiting patients. Initially posted on May 11th 2020 and last updated in December 1st 2022, the study has yet to begin enrollment. However, there are 293 other studies actively enrolling participants at this time."
What aims does this experiment seek to achieve?
"This investigation intends to measure the impact of pre-therapy and post-therapy conditions on Apnea Hypopnea Index (AHI). Secondary goals include comparing sleep quality questionnaires with Pittsburgh Sleep Quality Index (PSQI) and Epsworth Sleepiness Score (ESS), as well as assessing snoring levels via a visual analogue scale reported by their sleeping partner."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger